Business / Finance

RSS

Edgewater, Haldimand sign deal to acquire supply chain services from SSW

Haldimand War Memorial Hospital and Edgewater Gardens select Shared Services West as its Preferred Supplier for Supply Chain Services.

18 Apr 2011

Amylin reports total revenue of $152.7 million for quarter ended March 31, 2011

Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2011.

18 Apr 2011

Prism Medical acquires Movement 2

Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced the acquisition of Movement 2 Ltd., a provider of home care patient moving and handling equipment, servicing and repair in the East Midlands region of the UK.

18 Apr 2011

Nuvo Research to acquire ZARS Pharma

Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.

18 Apr 2011

Biotech Synergy concludes EP-2101 asset transfer, cancer epitopes related portfolio

Biotech Synergy has concluded the asset transfer of multi-epitope cancer vaccine product formerly known as EP-2101 and cancer epitopes related portfolio. Emile Loria, M.D., former President and Chief Business Officer of IDM and former President & CEO of Epimmune, is the founder of Biotech Synergy.

18 Apr 2011

Health care continues to shine in the U.S. Real Estate Investment Trust world

Health care continues to be a shining star in the U.S. Real Estate Investment Trust world, and with recently announced or closed transactions, public companies' hold on the ever-growing market will continue to soar.

16 Apr 2011

Best Practices develops Market Research Excellence Services for business executives

The Market Research function plays a critical role in helping companies make informed decisions, avoid risk, and uncover opportunities for growth. Although Market Research insights can be vital to corporate success, the function's full value often remains unrealized.

16 Apr 2011

Merck expects 2011 non-GAAP EPS to be in the range of $3.64 to $3.76

Following the Merck and Johnson & Johnson settlement announcement today, Merck said that it continues to expect 2011 non-GAAP earnings per share to be in the range of $3.64 to $3.76, excluding certain items.

16 Apr 2011

Johnson & Johnson provides further details regarding distribution rights for REMICADE, SIMPONI

Johnson & Johnson provided additional information today on its amended agreement with Merck regarding distribution rights for REMICADE (infliximab) and SIMPONI (golimumab) in markets outside the United States. The amended agreement announced today in a separate news release from both companies concludes a pending arbitration, which had been filed by Johnson & Johnson in May 2009.

16 Apr 2011

Merck begins tender offer for all Inspire shares

Merck, known as MSD outside the United States and Canada, today announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00 per share in cash without interest and less any applicable withholding taxes.

15 Apr 2011

RXi prices underwritten public offering of 11,950,000 shares of common stock

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using immunotherapy and RNA-targeted technologies, today announced that it has priced an underwritten public offering of 11,950,000 units at a price to the public of $1.00 per unit for gross proceeds of approximately $12 million.

15 Apr 2011

Alliance HealthCare Services acquires 24/7 Radiology

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced the acquisition of 24/7 Radiology, a professional radiology services company, which provides both preliminary and final professional radiology interpretation services for MRI, CT, ultrasound, X-Ray and other imaging modalities in 18 states.

15 Apr 2011

RXi Pharmaceuticals acquires Apthera

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced the completion of its previously announced acquisition of Apthera, Inc.

15 Apr 2011

SXC enters definitive agreement to acquire MedMetrics

SXC Health Solutions Corp., announced today it has entered into a definitive agreement to acquire substantially all of the assets of MedMetrics Health Partners, Inc., the full-service PBM subsidiary of Public Sector Partners, Inc. which is affiliated with a major medical school.

12 Apr 2011

Shrink Nanotechnologies to acquire Nanopoint

Shrink Nanotechnologies, Inc., an innovative high technology company, announced today that it has executed a binding letter of intent to acquire 100% of Hawaii-based Nanopoint Inc., a biomedical instrumentation and microfluidics company with global distribution for its award-winning suites of life sciences products.

12 Apr 2011

Nano Terra announces acquisition of Surface Logix

Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.

12 Apr 2011

Biomet net sales increase 1% to $678 million for third fiscal quarter 2011

Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2011.

12 Apr 2011

VitaminSpice receives revised PO from West & Associates for $6.94 million

VitaminSpice has received a revised purchase order that increases the previous $5 million, March 9, 2011 Purchase Order, to $6.94 million. VitaminSpice received the revised PO from West and Associates, Las Vegas.

12 Apr 2011

Novelos Therapeutics acquires Cellectar

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has completed its acquisition of Cellectar, Inc., a Wisconsin-based drug development company, in a stock-for-stock transaction.

12 Apr 2011

Lantheus begins exchange offer for eligible holders

NLantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that on April 8, 2011 it commenced an exchange offer for eligible holders to exchange any and all of the company's outstanding unregistered 9.75% Senior Notes due 2017.

11 Apr 2011